Clinical trials
Recruiting Carcinoma, Ovarian Epithelial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 6 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 7 |
| 2024 | 9 |
| 2025 | 12 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 66 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Beijing Biotech | 3 |
| Blue Earth Diagnostics | 2 |
| Cukurova University | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| National Cancer Center, Korea | 2 |
| 858 Therapeutics, Inc. | 1 |
| AGO Research GmbH | 1 |
| AbbVie | 1 |
| Alexandria University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 66 |
| Fallopian Tube Neoplasms | 23 |
| Ovarian Neoplasms | 23 |
| Stomach Neoplasms | 9 |
| Colorectal Neoplasms | 8 |
| Endometrial Neoplasms | 8 |
| Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Breast Neoplasms | 4 |
Trials
Showing 51 to 66 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.